Yes, all suspected adverse reactions to Mounjaro should be reported via the Yellow Card Scheme, particularly serious reactions, those causing hospitalisation, or any reactions not documented in the Summary of Product Characteristics
Bi vit gii p thc mc Glutathione c tt cho ln da ca bn khng
Aunque con el tiempo uno se queme menos, sigue acumulando dao que favorece el envejecimiento prematuro y el cncer cutneo, concluye
This interim analysis used data from completed surveys only
The recommended starting point for finding UK trials is: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) the UK's public-facing portal for finding and joining clinical research studies ClinicalTrials.gov and the EU Clinical Trials Register international registries of ongoing studies, including the REDEFINE and TRIUMPH programmes Referral via a GP or specialist to a trial centre In the meantime, men with obesity or type 2 diabetes should be aware that NICE-approved treatments are already available and may offer meaningful clinical benefit: Semaglutide (Wegovy) is approved by NICE (TA875) for weight management in adults with a BMI 35 kg/m (or lower thresholds for certain ethnic groups) and at least one weight-related comorbidity, subject to specialist tier service criteria and duration requirements
